Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Atovaquone 💬
(ATOVAQUONE ORAL SUSPENSION)		1件: Atovaquone1件: Atovaquone--1件: 61 💬
2 Caffeine citrate 💬
(CAFFEINE CITRATE ORAL SOLUTION)		1件: Caffeine1件: Caffeine11件: ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬 		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 13, 21, 46, 96, 97, 265 💬
3 Cetirizine hydrochloride 💬
(CETIRIZINE HYDROCHLORIDE ORAL SOLUTION)		1件: Cetirizine3件: Cetirizina; Cetirizine; Cetirizine hydrochloride1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 13, 19, 35, 300, 309 💬
4 Chlorhexidine gluconate 💬
(ACCLEAN CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE ORAL RINSE, CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE, CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION, CLEANCARE CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, DASH CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE, MAJOR ORAL RINSE, SKY ORAL RINSE)		1件: Chlorhexidine2件: Chlorhexidine; Chlorhexidine gluconate--2件: 86, 299 💬
5 Deferasirox 💬
(DEFERASIROX ORAL, DEFERASIROX ORAL GRANULES)		1件: Deferasirox1件: Deferasirox--4件: 54, 254, 284, 286 💬
6 Deflazacort 💬
(DEFLAZACORT ORAL SUSPENSION)		1件: Deflazacort1件: Deflazacort1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 30, 113 💬
7 Enalapril maleate 💬
(ENALAPRIL MALEATE ORAL SOLUTION)		1件: Enalapril2件: Enalapril; Enalapril maleate1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 13, 46, 66, 113, 210, 222, 279 💬
8 Escitalopram oxalate 💬
(ESCITALOPRAM ORAL SOLUTION)		1件: Escitalopram3件: Citalopram; Escitalopram; Escitalopram oxalate1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬4件: 2, 6, 13, 46 💬
9 Fentanyl citrate 💬
(Oralet (TN))		1件: Fentanyl1件: Fentanyl1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬5件: 46, 70, 97, 231, 298 💬
10 Glycopyrrolate 💬
(GLYCOPYRROLATE ORAL SOLUTION)		1件: Glycopyrronium1件: Glycopyrrolate1件: CHRM3 💬 12件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 6, 34 💬
11 Itraconazole 💬
(ITRACONAZOLE ORAL)		1件: Itraconazole1件: Itraconazole--7件: 2, 3, 65, 96, 97, 227, 299 💬
12 Lacosamide 💬
(LACOSAMIDE ORAL SOLUTION)		1件: Lacosamide1件: Lacosamide2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
13 Metformin hydrochloride 💬
(METFORMIN HYDROCHLORIDE ORAL SOLUTION)		1件: Metformin3件: Metformin; Metformin hydrochloride; Metformina2件: PRKAA,
PRKAA 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬27件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 81, 84, 86, 97, 113, 127, 158, 206, 218, 225, 265, 285, 298, 299, 301 💬
14 Naproxen 💬
(NAPROXEN ORAL SUSPENSION)		1件: Naproxen3件: Naproxen; Naproxen sodium; Propanoic acid2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271 💬
15 Nitrofurantoin 💬
(NITROFURANTOIN ORAL SUSPENSION)		1件: Nitrofurantoin1件: Nitrofurantoin--1件: 13 💬
16 Oseltamivir phosphate 💬
(OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION)		1件: Oseltamivir1件: Oseltamivir--2件: 97, 299 💬
17 Oxycodone hydrochloride 💬
(OXYCODONE HYDROCHLORIDE ORAL SOLUTION)		1件: Oxycodone2件: Oxycodone; Oxycodone hydrochloride3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 46, 70, 226, 298 💬
18 Potassium chloride 💬
(POTASSIUM CHLORIDE FOR ORAL SOLUTION)		1件: Potassium chloride1件: Potassium chloride--1件: 97 💬
19 Sevelamer carbonate 💬
(SEVELAMER CARBONATE FOR ORAL SUSPENSION)		1件: Sevelamer1件: Sevelamer--2件: 235, 238 💬
20 Triamcinolone acetonide 💬
(ORALONE)		1件: Triamcinolone3件: Triamcinolone; Triamcinolone acetonide; Triamcinolone hexacetonide1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 46, 53, 56, 90, 96, 107, 226, 298 💬
21 Valganciclovir hydrochloride 💬
(VALGANCICLOVIR HYDROCHLORIDE FOR ORAL)		1件: Valganciclovir1件: Valganciclovir--6件: 28, 60, 85, 97, 299, 331 💬
22 Vancomycin hydrochloride 💬
(VANCOMYCIN HYDROCHLORIDE FOR ORAL SOLUTION)		1件: Vancomycin1件: Vancomycin--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
23 Vigabatrin 💬
(VIGABATRIN FOR ORAL SOLUTION)		1件: Vigabatrin1件: Vigabatrin1件: ABAT 💬 6件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬2件: 145, 158 💬